Search results
Results from the WOW.Com Content Network
A noninvasive tool for predicting dementia and stroke risk may also help assess someone’s risk of developing ... as some early research has started to indicate that some antidepressants, such as ...
The Medication Appropriateness Tool for Comorbid Health conditions during Dementia (MATCH-D) criteria supports clinicians to manage medication use specifically for people with dementia without focusing only on the management of the dementia itself.
The LUNSERS is designed to monitor medication-induced side effects. This psychiatric assessment tools allows for the monitoring of side effects related to neuroleptic (or anti-psychotic) medications. The test is a self-reported check-tick box format with a predefined scale from "not at all" to "very much".
Antidepressants have been associated with an increased risk of dementia in older adults. [133] Researchers have developed a tool that allows people to rate their concern about common side effects of antidepressants.
Dementia prevention is a critical area of research, as experts want to understand what people can do to decrease dementia risk. A recent study found that more than 5 years of taking medications ...
This technique may be used if your medication puts you at risk for withdrawal symptoms, which may occur when some antidepressants are stopped without a gradual taper. Taper and moderate switch.
In 2005, the FDA issued an advisory warning of an increased risk of death when atypical antipsychotics are used in dementia. [47] In the subsequent 5 years, the use of atypical antipsychotics to treat dementia decreased by nearly 50%. [47] As of now, the only FDA-approved atypical antipsychotic for alzheimer-related dementia is brexpiprazole.
Not only that, they had a 52 percent lower risk of vascular dementia, and a 39 percent lower risk of Alzheimer’s dementia. People who took SGLT-2 inhibitors for longer periods of time seemed to ...